Tuesday, July 21
10:30 am - 12:00 pm
BIO World Congress on Industrial Biotechnology workshops are designed for specific and focused discussions on business or technical information. Workshops are open to attendees with full access conference registrations.
2015 Workshop Sponsors:
Bioproduct Supply Chains In Action
It is recognized that the journey to having full scale industrial uptake of biomaterials is a long and arduous one. This workshop focuses on distinct supply chains that were precipitated by an idea or a company need that, through collaboration and strategic support from industry and government sources, were able to be created. In one example, processed hemp was turned into green building materials that were subsequently used to construct new offices for a hemp food processor. In a second example, processed flax was used in a thermoplastic electronic casing. In a third example, a needle punch wood/natural fibre based mat line was implemented to provide materials for automotive applications. Key criteria related to supply chain development will be discussed using these examples to demonstrate what works and what does not.
Sean McKay, Composites Innovation Centre
Sean McKay, Composites Innovation Centre
Wendy Wu, Plains Industrial Hemp Processing
Jeremy Lang, Open Mind Developments
Alvin Ulrich, Biolin Research
Dan Madlung, BioComposites Group
Tam Tekle, TTS
Practical Magic: Genomics, Phenomics and the Next Generation of Advanced Materials
By 2020 it is anticipated that advanced biomaterials will occupy a significant market share in the automotive, construction, aerospace and consumer products industries – equivalent to the growing market penetration of biofuels. A vital component of the strategy to achieve this goal is the harnessing of modern biotechnology to control the phenotype of natural materials via gene regulation and expression in a highly targeted manner. This panel session will discuss current biomaterials industry and market trends together with essential quality assurance innovations. The transformative impact of novel genomics-enabled technologies on manufacturing costs and increased sales for a specific, real-world example from the automotive sector will be described as an exemplar of the potential of this approach to building the next generation of sustainable and economic industrial materials.
Simon Potter, Composites Innovation Centre
David Levin, University of Manitoba
Michael Deyholos, University of British Columbia
Simon Potter, Composites Innovation Centre / FibreCITY
Chris Barker, Genome Prairie
Value of Biobased in a Period of Low Oil Prices
At the time of the World Congress in 2014, the price of oil was over $100/barrel, many new renewable chemicals and biobased products had been commercialized, and there was significant optimism in the biorenewable space. Now, in mid-2015, the price of oil has plummeted to its lowest point since early 2009, and the bioeconomy appears much more fragile. Now, more than ever, it is vital for industrial biotechnology companies to understand and communicate the value of renewable chemicals and biobased products. Succinity, a joint venture between BASF and Corbion Purac, is pleased to present a panel of speakers with intimate knowledge of the value that can be gained through biobased chemistry. The diverse panel, representing the value chain from intermediate producer through brand owner, will discuss strategic benefits of biobased, such as the feedstock diversification, improved economics, environmental benefits, enhanced performance, sustainability benefits, and improved brand equity. Please join us as we lead an informative discussion on the value of biobased in the face of falling oil prices.
Markus Pompejus, BASF Corporation
Markus Hummelsberger, Succinity GmbH
Dennis Hall- OBIC
Hans van der Pol, Corbion
Chantal Bergeron, Seventh Generation
Protecting Valuable IP in the Face of New Challenges to Patent Eligibility
Inventors and companies in biotechnology-related industries seeking patent protection on inventions now find themselves confounded by changing rules on what inventions are eligible for patenting. Patent eligibility rules and related issues impacting patent rights and enforcement have recently come to the forefront as a result of recent cases from United States Supreme Court as interpreted by the lower U.S. courts and the United States Patent and Trademark Office. This workshop will focus on the current state of patent eligibility in the U.S. based on precedential case law, and consider recent guidance for patent examiners adopted by the United States Patent and Trademark Office as compared to patent offices around the world. In assessing how the climate has changed for patenting industrial biotechnology innovations, the workshop will consider the benefits and risks of trade secret protection, the most logical substitute for maximizing IP value when patenting may not be possible.
Sharon E. Roberg-Perez, Robins Kaplan LLP
Joseph Taffy, Thermo Fisher Sciences, Inc.
Matt McFarlane, Robins Kaplan LLP
Peter Jackman, Sterne Kessler Goldstein Fox
Lee Walko, Omni Tech International
Hans Sauer, BIO
The Key Requirements Of Equity Investors To Invest Into Renewable Chemicals, Bioproducts And Advanced Biofuels Companies and Projects
A panel of highly motivated and significant equity investors, led by a trio of renowned moderating experts, will identify and examine the key concerns and requirements of angels, family offices, venture capital, private equity, strategic capital, infrastructure funds, institutional, public equity and other funders to invest into renewable chemicals, bioproducts and advanced biofuels at the technology company, project and portfolio levels.
John May, Stern Brothers & Co.
John Kirkwood, Krieg DeVault LLP
Mark Riedy, Kilpatrick Townsend & Stockton LLP
Brian Baynes, Flagship Ventures
Tom Huot, Vantage Point
Christian Barker, Stern Brothers & Co.
Geoff Duyk, MD, PhD, TPG
Ludwig Goris, Capricorn Ventures
Michael Knutzen, The Coca-Cola Company